304 related articles for article (PubMed ID: 26688298)
1. Tolerogenic Dendritic Cells Generated by In Vitro Treatment With SAHA Are Not Stable In Vivo.
Thewissen K; Broux B; Hendriks JJ; Vanhees M; Stinissen P; Slaets H; Hellings N
Cell Transplant; 2016; 25(6):1207-18. PubMed ID: 26688298
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity.
Kim WS; Kim H; Kwon KW; Im SH; Lee BR; Ha SJ; Shin SJ
Oncotarget; 2016 Jun; 7(23):33765-82. PubMed ID: 27172902
[TBL] [Abstract][Full Text] [Related]
3. Selective depletion of CD11c
Wang L; Li Z; Ciric B; Safavi F; Zhang GX; Rostami A
Eur J Immunol; 2016 Oct; 46(10):2454-2466. PubMed ID: 27338697
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy using lipopolysaccharide-stimulated bone marrow-derived dendritic cells to treat experimental autoimmune encephalomyelitis.
Zhou F; Ciric B; Zhang GX; Rostami A
Clin Exp Immunol; 2014 Dec; 178(3):447-58. PubMed ID: 25138204
[TBL] [Abstract][Full Text] [Related]
5. Delivery of alloantigens via apoptotic cells generates dendritic cells with an immature tolerogenic phenotype.
Gleisner MA; Rosemblatt M; Fierro JA; Bono MR
Transplant Proc; 2011; 43(6):2325-33. PubMed ID: 21839264
[TBL] [Abstract][Full Text] [Related]
6. Vorinostat, a histone deacetylase inhibitor, suppresses dendritic cell function and ameliorates experimental autoimmune encephalomyelitis.
Ge Z; Da Y; Xue Z; Zhang K; Zhuang H; Peng M; Li Y; Li W; Simard A; Hao J; Yao Z; Zhang R
Exp Neurol; 2013 Mar; 241():56-66. PubMed ID: 23261766
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cells transduced with SOCS-3 exhibit a tolerogenic/DC2 phenotype that directs type 2 Th cell differentiation in vitro and in vivo.
Li Y; Chu N; Rostami A; Zhang GX
J Immunol; 2006 Aug; 177(3):1679-88. PubMed ID: 16849477
[TBL] [Abstract][Full Text] [Related]
8. Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4.
Weatherill AR; Lee JY; Zhao L; Lemay DG; Youn HS; Hwang DH
J Immunol; 2005 May; 174(9):5390-7. PubMed ID: 15843537
[TBL] [Abstract][Full Text] [Related]
9. The histone demethylase inhibitor GSK-J4 limits inflammation through the induction of a tolerogenic phenotype on DCs.
Doñas C; Carrasco M; Fritz M; Prado C; Tejón G; Osorio-Barrios F; Manríquez V; Reyes P; Pacheco R; Bono MR; Loyola A; Rosemblatt M
J Autoimmun; 2016 Dec; 75():105-117. PubMed ID: 27528513
[TBL] [Abstract][Full Text] [Related]
10. The mouse dendritic cell marker CD11c is down-regulated upon cell activation through Toll-like receptor triggering.
Singh-Jasuja H; Thiolat A; Ribon M; Boissier MC; Bessis N; Rammensee HG; Decker P
Immunobiology; 2013 Jan; 218(1):28-39. PubMed ID: 22445076
[TBL] [Abstract][Full Text] [Related]
11. Disease-modifying capability of murine Flt3-ligand DCs in experimental autoimmune encephalomyelitis.
Papenfuss TL; Kithcart AP; Powell ND; McClain MA; Gienapp IE; Shawler TM; Whitacre CC
J Leukoc Biol; 2007 Dec; 82(6):1510-8. PubMed ID: 17855499
[TBL] [Abstract][Full Text] [Related]
12. Tolerogenic Dendritic Cells Generated with Tofacitinib Ameliorate Experimental Autoimmune Encephalomyelitis through Modulation of Th17/Treg Balance.
Zhou Y; Leng X; Luo S; Su Z; Luo X; Guo H; Mo C; Zou Q; Liu Y; Wang Y
J Immunol Res; 2016; 2016():5021537. PubMed ID: 28070525
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of nuclear factor-kappa B enhances the capacity of immature dendritic cells to induce antigen-specific tolerance in experimental autoimmune encephalomyelitis.
Iruretagoyena MI; Sepúlveda SE; Lezana JP; Hermoso M; Bronfman M; Gutiérrez MA; Jacobelli SH; Kalergis AM
J Pharmacol Exp Ther; 2006 Jul; 318(1):59-67. PubMed ID: 16597709
[TBL] [Abstract][Full Text] [Related]
14. Experimental autoimmune encephalomyelitis (EAE) induced by antigen pulsed dendritic cells in the C57BL/6 mouse: influence of injection route.
Aghdami N; Gharibdoost F; Moazzeni SM
Exp Anim; 2008 Jan; 57(1):45-55. PubMed ID: 18256518
[TBL] [Abstract][Full Text] [Related]
15. Reduction of graft-versus-host disease by histone deacetylase inhibitor suberonylanilide hydroxamic acid is associated with modulation of inflammatory cytokine milieu and involves inhibition of STAT1.
Leng C; Gries M; Ziegler J; Lokshin A; Mascagni P; Lentzsch S; Mapara MY
Exp Hematol; 2006 Jun; 34(6):776-87. PubMed ID: 16728283
[TBL] [Abstract][Full Text] [Related]
16. Generation of dendritic cells with regulatory properties.
Ureta G; Osorio F; Morales J; Rosemblatt M; Bono MR; Fierro JA
Transplant Proc; 2007 Apr; 39(3):633-7. PubMed ID: 17445563
[TBL] [Abstract][Full Text] [Related]
17. Intravenous transfer of apoptotic cell-treated dendritic cells leads to immune tolerance by blocking Th17 cell activity.
Zhou F; Lauretti E; di Meco A; Ciric B; Gonnella P; Zhang GX; Rostami A
Immunobiology; 2013 Aug; 218(8):1069-76. PubMed ID: 23587571
[TBL] [Abstract][Full Text] [Related]
18. Irisflorentin modifies properties of mouse bone marrow-derived dendritic cells and reduces the allergic contact hypersensitivity responses.
Fu RH; Tsai CW; Tsai RT; Liu SP; Chan TM; Ho YC; Lin HL; Chen YM; Hung HS; Chiu SC; Tsai CH; Wang YC; Shyu WC; Lin SZ
Cell Transplant; 2015; 24(3):573-88. PubMed ID: 25654487
[TBL] [Abstract][Full Text] [Related]
19. Apicidin, the histone deacetylase inhibitor, suppresses Th1 polarization of murine bone marrow-derived dendritic cells.
Jung ID; Lee JS; Jeong YI; Lee CM; Chang JH; Jeong SK; Chun SH; Park WS; Han J; Shin YK; Park YM
Int J Immunopathol Pharmacol; 2009; 22(2):501-15. PubMed ID: 19505402
[TBL] [Abstract][Full Text] [Related]
20. Oxygen tension regulates the in vitro maturation of GM-CSF expanded murine bone marrow dendritic cells by modulating class II MHC expression.
Goth SR; Chu RA; Pessah IN
J Immunol Methods; 2006 Jan; 308(1-2):179-91. PubMed ID: 16406060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
